Sotera Health Company

    Jurisdiction
    United States
    ISIN
    US83601L1026 (SHC)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    Fair value (Benjamin Graham formula)
    €15.03 4.3% undervalued
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    6 / 7

    Profile

    Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €964.85M
    Gross margin
    55.5%
    EBIT
    €276.64M
    EBIT margin
    28.7%
    Net income
    €20.61M
    Net margin
    2.1%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €1.06B +9.6% €219.40M +964.5%
    €1.12B +6.3% €246.32M +12.3%
    €1.21B +7.6% €285.17M +15.8%

    Dividends

    No dividend payouts

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Rutz Michael P President of Sterigenics -127K $16.38 -$2.07M

    Earnings Calls

    Latest earnings call: August 8, 2025

    Add to watchlist

    Notifications